Riluzole for the treatment of amytrophic lateral sclerosis: an assessment of clinical efficacy and safety
By: Canadian Coordinating Office for Health Technology Assessment
Publisher: Canadian Coordinating Office for Health Technology Assessment
Place of publication: Ottawa
Number of pages: 28
Subjects: Amyotrophic lateral sclerosis -- drug therapy; Neuroprotective agents -- therapeutic agents
Notes: "August 2004" Technology Report

2